About
VenomAid Diagnostics is a Danish medtech company founded in 2018, focused on improving snakebite care globally. The company develops affordable, rapid diagnostic tools that identify snake venom in a patient's bloodstream using a small blood sample. This capability allows healthcare workers to quickly administer the correct antivenom, enhancing survival rates and reducing long-term disabilities caused by snakebites. The primary product is a portable, in vitro diagnostic device designed for point-of-care use. It leverages advanced antibody discovery to ensure accuracy and ease of use. VenomAid targets healthcare providers and government health agencies, particularly in resource-poor rural areas where snakebite incidents are high. The company has raised significant funding to support its mission and aims to minimize fatalities and disabilities from snakebites, aligning with global health priorities.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2018
-
Total Funding $1000000
Location
331 Elektrovej, Lyngby, Capital Region of Denmark, Denmark, 2800